Ari Maizel, M.B.A.

Ari Maizel, M.B.A.

Chief Commercial OfficeratAxsome Therapeutics· In proxies 2023–2025

Pay in FY20250% from the year before · Axsome Therapeutics stock +115.9% the same year

Ari Maizel, M.B.A. was paid $3.2M in FY2025 (Dec), the same as the year before. Axsome Therapeutics stock rose 115.9% that year.

Pay$100 in the stock at the end of FY22 → $237
Pay is from the Summary Compensation Table of each Axsome Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Axsome TherapeuticsPublic company · 3 yr
    • Chief Commercial Officer2023 – Present · 3 yrStock in role +90%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?